• Profile
Close

Issue detailed bills to patients mentioning cost of stents: Minister

IANS Mar 16, 2017

National Pharmaceuticals Pricing Authority (NPPA) has directed hospitals to issue detailed bills to the patients, specifically and separately mentioning the cost of the coronary stents, along with the brand name of the manufacturer and importer, batch number and other details, said Minister of State for Chemical and Fertilisers Mansukh Mandaviya on Tuesday.

 

 

In a written reply to Lok Sabha, Mandaviya also said that non-compliance thereof will be treated as deliberate distortion of evidence along with charges of overpricing inviting prosecution under the Essential Commodities Act. 

"Through NPPA, is closely monitoring the situation and has alerted the State Governments and State Drugs Controllers to monitor the availability of stents. Industry has also been apprised that all manufactures and importers are under legal obligation to maintain smooth production and supply of coronary stents of all brands which were available in the country before price cap," said Mandaviya.

Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay